Variable number tandem repeat (VNTR) analysis at nine loci of isolates of Pseudomonas aeruginosa submitted to the national reference laboratory from UK hospitals, from over 2000 patients, between June 2010 and June 2012 revealed four widely found types that collectively were received from approximately a fifth of patients, including from those with cystic fibrosis. These types were also prevalent among related submissions from the clinical environment and were received from up to 54 (out of 143) hospitals. Multi-locus sequence typing and bla OXA-50-like sequencing confirmed the clonal relationship within each cluster, and representatives from multiple centres clustered within about 70 % by pulsed-field gel electrophoresis. Illumina sequencing of 12 isolates of cluster A of VNTR profile 8, 3, 4, 5, 2, 3, 5, 2, x (where the repeat number at the last, most discriminatory locus is variable) revealed a large number of variably present targets in the accessory genome and seven of these were sought by PCR among a larger set of isolates. Representatives from patients within a single centre mostly had distinct accessory gene profiles, suggesting that these patients acquired the strain independently, while those with clear epidemiological links shared the same profile. Profiles also varied between representatives from different centres. Epidemiological investigations of widely found types such as these require the use of finer-typing methods, which increasingly will be informed by next generation sequencing.
INTRODUCTION
Pseudomonas aeruginosa is commonly found in moist environments and water and can cause opportunistic infections in vulnerable patients, such as those that are immunocompromised, critically ill, or in some way deficient in anatomical barriers (e.g. those with burns or undergoing invasive procedures) (Remold et al., 2011; Qin et al., 2012) . It is often associated with multiple antibiotic resistances (Kerr & Snelling, 2009; Lister et al., 2009; Fera et al., 2011; Davies et al., 2011; Ashish et al., 2012a) . Our laboratory provides a typing service for this organism for hospitals in the UK. These include isolates from suspected nosocomial outbreaks, potential incidences of cross-infection, and surveillance among patients with cystic fibrosis (CF), in whom infection with this organism often becomes chronic and is associated with a steady decline in lung function (McPhail et al., 2008) . Isolates from the clinical environment are also often typed, to try to identify potential sources that may be associated with infections/colonizations.
A survey of isolates of P. aeruginosa from patients with CF carried out in our laboratory (Scott & Pitt, 2004) identified clusters of highly similar isolates that were found from multiple patients from a number of centres, the most important of which are the 'Liverpool', 'Midlands 1' and 'Manchester' strains; there is also 'clone C', which has been widely described from both patient and environmental samples (Römling et al., 2005) . There have also been other descriptions of strains that are common among CF patients (Armstrong et al., 2003; Aaron et al., 2010; Fothergill et al., 2012) . Since they are found in many patients, these are often regarded as transmissible strains, and segregation is practised in some clinics to prevent the risk of cross-infection (Jones et al., 2010; Griffiths et al., 2012; Ashish et al., 2012b) . The most recent CF guidelines (https://www.cysticfibrosis.org. uk/media/82034/CD_Laboratory_Standards_Sep_10.pdf) recommend that centres carry out screening for crossinfection among CF patients in the UK. Since ours is the only laboratory providing a typing service for this organism, we receive isolates from a high proportion of CF patients harbouring P. aeruginosa, allowing us to study the population structure among these patients. Since we also receive isolates from non-CF patients and the clinical environment, we have the opportunity of putting these strains into a wider context.
Since 2009, we have been using variable number tandem repeat (VNTR) analysis at nine loci to type this organism, a method that has been extensively evaluated against pulsedfield gel electrophoresis (PFGE) (Turton et al., 2010) . Here, we describe the VNTR results obtained on isolates received over a 2-year period between June 2010 and June 2012 across the different patient groups and environmental sites, together with our further studies of some of the most prevalent types found.
METHODS
Isolates were submitted for typing from hospitals in the UK. The 2-year set consisted of 3870 isolates received between June 2010 and June 2012. This included 726 environmental isolates, from 47 hospitals. To prevent bias from multiple isolates from some patients, the patient set was reduced to one isolate per VNTR profile per patient, giving 2325 entries from 2230 patients (of which approximately 54 % were CF patients) from 143 centres; isolates differing only at the last locus were regarded as representing the same type. Additional isolates predating June 2010 were also included in studies of four widely found clusters. A representative of each of the clusters described has been deposited in the National Collection of Type Cultures (NCTC) (NCTC 13618, NCTC 13619, NCTC 13620 and NCTC 13621 for clusters A, B, C and D, respectively). NCTC 13618, NCTC 13620 and NCTC 13621 correspond to isolates AS3, C17 and D22, respectively.
Typing. Typing was carried out by VNTR analysis at nine loci, as described previously (Turton et al., 2010) with the exception that forward primers for loci ms207, ms209 and ms61 were labelled with 6-FAM, NED and VIC, respectively. Fragment analysis was carried out on an ABI sequencer. FSA files generated were analysed using PeakScanner software. Isolates were compared using BioNumerics
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Additional typing on representative isolates was carried out using PFGE of SpeI-digested genomic DNA and bla OXA-50-like sequencing, as described previously (Turton et al., 2010) . Multi-locus sequence typing (MLST) was carried out as described by Curran et al. (2004) , with use of the Pseudomonas aeruginosa MLST website (http://pubmlst.org/ paeruginosa/) at the University of Oxford (Jolley et al., 2004) .
Identification of variably present accessory gene targets.
Illumina sequencing was carried out on 12 isolates of profile 8, 3, 4, 5, 2, 3, 5, 2, x (where the repeat number at the last, most discriminatory locus is variable) received between 2006 and 2011 from nine centres, which included representatives from each of the source groups (CF and non-CF patients and environmental isolates) (isolates AS1 to AS11 in Fig. 2 ). Genomic DNA was prepared using a GeneJET Genomic DNA Purification kit (Fermentas, Thermo Fisher Scientific) and subjected to Illumina sequencing using the service provided by the University of Birmingham; one isolate was in addition sequenced on a Roche 454. The Illumina sequences were assembled using velvet (www.ebi.ac.uk/~zerbino/velvet/) version 1.2.08 and the velvet_optimiser wrapper script (http://bioinformatics.net.au/software. velvetoptimiser.shtml) version 2.24 using k values of between 35 and 65. The 454 sequence was assembled using Newbler (Roche, version 2.5.3). A novel method termed CoreAccess (A. Underwood, unpublished) was used to cluster the genes from all the genomes in the study and those of published genomes (LESB58, M18, PAO1, UCBPP-PA14, NCGM2.S1 and PA7). Briefly, the protein sequences of all genes from all the P. aeruginosa genomes were used as input for the program cd-hit (Li & Godzik, 2006) . These genes were either those already annotated in the sequence files of the GenBank entries or those predicted using Glimmer3 (Delcher et al., 2007) trained using the LESB58 sequence genes (NC_011770). The proteins were clustered using a hierarchical approach, as described on the cd-hit website (http://cd-hit.org). The final cut-off was 80 %. These clusters contained homologous proteins from the different genomes with the same or similar function. The information in the cd-hit output was collated into a sqlite3 database that was interrogated using SQL to find protein clusters that included a member from all the isolates. These represented the core genes. Those not in this set represented accessory genes ( Fig. S1 , available in JMM Online). The presence or absence of each gene in the accessory group was determined for each isolate and the profiles compared among the set and among the other genomes in the form of a 'heat-map' using Jexpress (http://jexpress.bioinfo.no/site/). Primers were designed to amplify a selection of these genes and PCR assays were carried out to determine whether they were present or absent in a wider set of isolates.
Accessory genome profiling. PS21 and LESF9 (both markers for the Liverpool strain) were sought using previously published primers (Fothergill et al., 2008) . Some targets used in the ArrayTube (AT) microarray (Wiehlmann et al., 2007) (PA0636, PA0722, PA0728, PA2185, PA2221, PA3835 and orfl) were sought using primers described in Table 1 . A search using Pathosystems Resource Integration Center (PATRIC) (http://patricbrc.org/portal/portal/patric) software, using the feature finder, had identified variable genes among available P. aeruginosa genomes from which we chose to seek putative phosphoadenosine phosphosulfate sulfotransferase (PPPS; PLES_32001) (using primers 59-CTGGACGTGGCACGCGAGTT-39 and 59-AGTG-GCAGGCAGACCCACCA-39 to amplify a 143 bp fragment) and clpP protease A (PLES_25421) genes. Primers to seek a selection of genes that sequencing had indicated were variably present among the 8, 3, 4, 5, 2, 3, 5, 2, x cluster were designed from those sequences ( Table 2 ). In particular, bacteriophage (17 putative variable targets found) and membrane protein targets (41 putative variable targets found) were sought; six of these were selected to further characterize isolates within the 8, 3, 4, 5, 2, 3, 5, 2, x cluster. Five targets (clpP, clusterA_5532, clusterA_1687, clusterA_7675 and clusterA_8125) were sought using a multiplex PCR among a wider set of isolates. Reactions were carried out in 25 ml volumes containing Qiagen multiplex mix (16), 5 pmol of each primer and 2 ml crude DNA extract. Thermocycler conditions were 95 uC for 15 min, followed by 35 cycles of 94 uC for 30 s, 55 uC for 90 s and 72 uC for 90 s, with a final extension at 72 uC for 10 min. Initial results were checked using single target PCR, to ensure that results were the same whether in a multiplex or single target format. Products were sequenced to confirm that the expected target had been amplified. ClusterA_8869 and LESF9 targets were sought separately using annealing temperatures of 57 uC and 53 uC, respectively. Single target reactions were carried out using the Qiagen core kit, according to the manufacturer's instructions. Amplification of the AT targets was carried out with addition of Q solution and additional MgCl 2 (to a final total concentration of 3 mM) and an annealing temperature of 60 uC, using the same thermocycler conditions as those for amplification of the VNTR loci. PCR products were separated by agarose gel electrophoresis followed by staining with GelRed (Cambridge Biosciences), or on a QIAxcel instrument (Qiagen) using the high-resolution cartridge. Sequences of the cluster A target genes have been deposited in GenBank; that of clusterA_8869, which is less than 200 bp, can be found in Fig. S1 .
RESULTS AND DISCUSSION
Review of isolates received between June 2010 and June 2012
Environmental isolates. During the 2-year period, 726 environmental isolates were received from 47 requestors with a wide geographical spread from England, Wales, Scotland, Northern Ireland and the Channel Islands. These were mainly from water, taps, sinks, plugs, drains, showers and baths, but there were also a small number from other sources, such as bronchoscopes (2), nebulizers (2) and endoscopy water (2); those from the latter sources (bronchoscopes, etc.) tended to be associated with specific outbreaks, rather than belonging to types that were seen more generally. Isolates Isolates were described according to cluster [A or AS, B, C or D, followed by a number (1-23)]. Hospitals were described by number (1-38), with different patients from each hospital being distinguished by a letter (A-K) following the hospital number. AS1 and AS3 were included in a previous study as P18 and P17, respectively (Turton et al., 2010) . Abbreviations: CF, cystic fibrosis patient; NCF, non-cystic fibrosis patient; Env, environmental; abd., abdominal; OPS, oropharyngeal swab; BAL; bronchoalveolar lavage; ST, sequence type.
Clusters of Pseudomonas aeruginosa in UK hospitals
were mainly from neonatal units, special care baby units, intensive care units (neonatal, paediatric and adult), and haematology and oncology wards. While many of the isolates had profiles associated with a particular outbreak or investigation, it was clear that there were a number of types that were found in multiple hospitals (Fig. 1b) . The most common of these were representatives of profile 12, 2, 1, 5, 5, 2, 4, 5, x (where x is the repeat number at the last locus and varied between 11 and 14) (cluster B), which, on the basis of having a similar VNTR profile to that of PA14 (VuThien et al., 2007) , probably corresponds to the PA14 clone, previously recognized as being widely found (Cramer et al., 2011) (Table 3) , and of profile 8, 3, 4, 5, 2, 3, 5, 2, x (x56-12) (cluster A), both of which were received in large numbers from many of the hospitals concerned (from up to 20 environmental sites in each case). Representatives of profile 10, 3, 5, 5, 4, 1, 3, 7/6, x (x58-10) (cluster D) and of clone C [11, 6, 2, 2, 1, 3, 7/8, 2/3, x (x58-13)] (cluster C) were also prevalent among environmental samples, having been received from nine and seven hospitals, respectively.
Patient isolates
While many patients harboured their own strains, or there were strains associated with particular outbreaks, it was clear that there were also a number of clusters of isolates with highly similar profiles from multiple patients attending different centres (Table 3 , Fig. 1a ). The most prevalent of these were clone C (cluster C), the Liverpool strain (each affecting approximately 6 % of patients, with the latter being found exclusively among CF patients), the 'PA14 clone' [12, 2, 1, 5, 5, 2, 4, 5, (x) (cluster B, affecting approximately 5.5 % of patients] and the two novel clusters also prevalent among environmental samples of profiles 8, 3, 4, 5, 2, 3, 5, 2, x (cluster A) and 10, 3, 5, 5, 4, 1, 3, 7, x (cluster D), affecting approximately 3 % and 2 % of patients, respectively. Together, clone C, the PA14 clone and the two novel clusters, all also prevalent among environmental isolates, affected approximately 17 % of patients. Typically, they were found from a relatively small number of patients per hospital, but from a large number of centres; for example, clone C was found from patients from 44 different centres. Isolates from CF patients were almost exclusively from sputum or cough swab samples and were mostly received for annual review of the strain type harboured by the patient and/or for surveillance for cross-infection among these patients. Isolates from non-CF Table 1 . Primers used to detect AT accessory targets 
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patients were, in parallel with the environmental isolates, mainly from neonatal units, special care baby units, intensive care units and oncology wards. Most isolates were from sputum, but they also included submissions from blood and wound swabs, as well as those from faecal, rectal, nose, axilla and groin screening, the latter particularly from babies following an incidence of infection on the ward, or when raised levels of P. aeruginosa had been found in water samples from sinks on the ward. Most submissions were received because of concerns that cross-infection might have occurred.
Characterization of clusters
PFGE analysis of multiple representatives (25-60) of each VNTR type, which included isolates from multiple hospitals and from each source group, divided the isolates into broad clusters corresponding to their VNTR type with an overall percentage similarity of about 70 % (Fig. 2) . However, there were clear band differences between some isolates within each cluster, both between and within centres (for example, cluster A isolates from hospital 6, or cluster D isolates from hospital 32). This is consistent with genomic rearrangements that have been described for both clone C and the PA14 clone (cluster B) (Cramer et al., 2011; Römling et al., 1997; Kresse et al., 2006) . Partial sequencing of the intrinsic bla OXA-50-like gene and MLST confirmed a clonal relationship within each cluster, with the isolates dividing into clear groups according to their VNTR type by these methods. Thus the ten representatives of the 8, 3, 4, 5, 2, 3, 5, 2, x cluster (cluster A) were found to belong to sequence type (ST) 27, with the exception of isolate A9 (ST 1402), which differed from ST 27 by a single nucleotide difference in the nuoD gene (allele 88 instead of allele 4), whilst those of the 12, 2, 1, 5, 5, 2, 4, 5, x cluster (cluster B), clone C (cluster C) and the 10, 3, 5, 5, 4, 1, 3, 7, x cluster (cluster D) belonged to STs 253, 17 and 395, respectively, the ST being consistent among all representatives (three or more) of each cluster typed. STs 253 and 17 are consistent with the designations of PA14 and clone C, respectively. Similarly, each cluster was associated with a particular bla OXA-50-like allele; these corresponded to allele 6 (GenBank accession number GQ141721, with the complete gene corresponding to that in isolate DK2 (GenBank accession CP003148, nt 6344318-6345106)), allele 12 (GQ141727) and allele 4 (GQ141719), described in a previous study by our laboratory (Turton et al., 2010) for clusters A, B and C, respectively, and allele 21 for cluster D (JX536393).
A selection of the accessory gene targets were sought among representatives of all the clusters, but the most detailed study was among representatives of cluster A. This type is relatively commonly found among CF patients, and is often PCR positive for one of the markers for the Liverpool strain (LESF9), giving rise to concerns that it may be readily transmissible. An initial survey of 11 isolates of this cluster, which included representatives from CF and non-CF patients from different centres and from environmental isolates, showed that all were PCR positive for PA0636, PA2185 and PA3835, and PCR negative for PA0722, PA0728, PA2221 and orfl included in the AT microarray panel, and for PS21. Testing of a further 15 isolates also chosen from across multiple requestors and source groups confirmed these results. PPPS was found in all isolates tested, and only presence or absence of clpP and LESF9 was variable among this set (Table 4 ). Since many of these targets failed to provide discrimination within the set of isolates, we sought to identify further variable targets among them by next generation sequencing.
The 12 isolates (AS1-AS12) belonging to this cluster subjected to Illumina sequencing were from nine hospitals, many of which were geographically distant from each other, and were from CF (6), non-CF (5) patients and an environmental source and had been isolated between 2006 and 2011 (Fig. 2 , Table 4 ). They therefore included isolates that were temporally, spatially and epidemiologically distant from one another, providing the best chance of finding those with differences between them. The presence or absence of genes from the accessory genome was compared by J-express, with the output being in the form of a heatmap dendrogram, which indicated 9452 sequences that varied between the various isolates (which included LESB58, M18, PAO1, UCBPP-PA14, NCGM2.S1 and PA7 from sequences available on GenBank), clearly suggesting a highly variable accessory genome among the 8, 3, 4, 5, 2, 3, 5, 2, x set. From the variably present targets, a number, particularly those that were phage related or encoded outer-membrane proteins, were selected and primers were designed to detect these by PCR among a wider set of isolates. Some of these targets (notably outermembrane protein targets) were found in all isolates tested, despite the heatmap suggesting that they were variably present among the set, perhaps because some alleles were sufficiently distinct that they did not cluster with the majority. Five of the most discriminatory targets identified were combined in a multiplex PCR, with two further targets also being sought. These targets encode a phage helicase, holin, hypothetical phage protein and clpP protease (phage related targets), a hypothetical protein with homology to one in Burkholderia pseudomallei which appears to be unique to this strain of P. aeruginosa and LESF9, which is a marker for the Liverpool strain. The Liverpool strain, however, normally has both LESF9 and PS21, while the latter was not detected in the 8, 3, 4, 5, 2, 3, 5, 2, x strain.
Detection of the variable accessory gene targets identified among the 8, 3, 4, 5, 2, 3, 5, 2, x cluster set, with particular emphasis on looking at isolates from the two centres with the largest number of patients with this strain, showed that the accessory gene profile was, with one exception only, consistent among isolates from a single patient (e.g. patients 2D and 2H), but distinct between patients (e.g. patients 2A and 2H) ( Table 4 ). In contrast, the set of Representatives of the Midlands 1 (12, 2, 5, 6, 3, 5, 5, 4, (x) and Manchester (9, 2, 3, -, 3, 2, 5, 3, (x) strains, previously described among CF patients, were received from 18 and 21 patients respectively. Percentages are among a total of 2230 patients. Environmental isolates were received from 47 requestors in connection with non-CF investigations. For many of these types, there were also a smaller number of single locus variants, differing by one repeat unit at one of the first eight loci; these were not included in the numbers, unless stated otherwise. Clusters A to H and the Liverpool and Manchester strains are marked in Fig. 1 *Profiles have a gap at one of the loci, or a repeat difference at one of the other loci. D76 of 11, 6, 2, 2, 1, 3, 7, 2, x; 38 of 11, 6, 2, 2, 1, 3, 7, 3, x; 14 of 11, 6, 2, 2, 1, 3, 8, 2, x; 6 of 11, 6, 2, 2, 1, 3, 8, 3, x. Clusters of Pseudomonas aeruginosa in UK hospitals Isolates were from 17 hospitals (1-17), with patients from the same hospital being distinguished by a letter (A-J) following the hospital number.
Results on a series of representatives from a single patient from hospital 2 and on an epidemiologically linked set from three patients from hospital 10 are highlighted in bold. Representatives from different patients were mostly associated with distinct accessory gene profiles. isolates (A11, A21 and A22) from non-CF patients with infections linked in space and time had the same accessory gene profile, consistent with the known epidemiological links. Isolates from two further patients (A27 and A30) from this centre also shared the same profile as one another, but one was from a CF patient and the other from 8, 3, 4, 5, 2, 3, 4, 2, 13 Cough swab
Clusters of Pseudomonas aeruginosa in UK hospitals a bronchiectasis patient, and it is unlikely that there would be any epidemiological link between them. The water and patient isolates from hospital 8 had a consistent accessory gene profile, supporting a link between them; these isolates also shared identical VNTR profiles and PFGE profiles. Apart from these examples, however, the accessory gene profiles were diverse between patients, within and between centres, an observation that does not support widespread transmission or common source exposure among them.
Elements of the accessory genome were also sought among 18-20 representatives distributed across the various groups and from multiple centres of each of the other clusters. The vast majority of isolates tested (73/76) were PCR positive for PPPS, irrespective of which cluster they belonged to. The gene clpP was variably present among isolates of clusters A (in 7/50 isolates), B (in 6/20 isolates) and C (in 3/16 isolates), but was not detected among representatives of cluster D (0/19). PS21 was not detected in any representatives of these four clusters, while LESF9 was only found among representatives of cluster A. Most isolates (18/20) of cluster B were PCR positive for PA0636 and orf1; all isolates tested (20/20) were PCR negative for PA2185. Some isolates of cluster B (2/7) were PCR positive for clusterA_1687, which is variably present in this cluster, as well as in cluster A. Among the clone C isolates, most isolates were PCR positive for PA0636 (12/16) and PA2185 (14/16). These were the most diverse in terms of their VNTR profile, which varied at the 7th and/or 8th locus, as well as at the last locus, and also showed the most variable results for these targets. Representatives of cluster D were all PCR negative for PA0636 and most (16/19) were PCR positive for PA2185. All were also PCR positive for PA0722. This set was the most diverse in terms of their PFGE profiles. Lack of detection of PA0636 may reflect a nucleotide substitution at the base corresponding to position 16 of the reverse primer (G instead of A, as seen in isolates DK2, M18 and UCBPP-PA14), rather than absence of this target.
Together, the results strongly suggest that most patients likely acquire these widely found cluster strains independently. The evidence from the accessory gene profiling is supported by the variation in repeat number at the last, most discriminatory locus in the VNTR profiles, the differences in banding patterns between PFGE profiles within a cluster and the fact that, while these types are common, they tend usually to be found in only relatively small numbers of patients per hospital. In most cases, there was no clear evidence that isolates belonging to the same cluster were related in terms of time of acquisition, as one might expect with an outbreak strain. This is difficult to assess, since we received multiple isolates from some CF patients, over a time period spanning more than the 2 years, but the representatives of each strain tended to be scattered among the batches of isolates received. There were some notable exceptions to this; the set of isolates of the 8, 3, 4, 5, 2, 3, 5, 2, x cluster from three patients with infections from a paediatric intensive care unit, which were clearly related in space and time, and isolates from 17 babies in a single centre colonized with the 12, 2, 1, 5, 5, 2, 4, 5, x strain (cluster B), 11 of which were received at the same time as one another; the remaining six were received 9 weeks later.
Our results agree with the observation of Pirnay et al. (2009) that clinical isolates are often indistinguishable from environmental isolates, and that they do not exhibit a specific disease habitat selection. These authors comment on the association of serotype O12 with multi-drug resistance and expansion in hospitals, as has also been noted by others (Woodford et al., 2011) . The clusters described here were associated with serotypes O1 (cluster A, clone C), O9 (cluster B) and O6 (cluster D) (data from our laboratory records). Our observations also agree with those of a study of clinical isolates from Italian hospitals, which showed an overlap of strains affecting CF and non-CF patients and that many of the genotypes belonged to a main cluster of clones (Ballarini et al., 2012) . Cramer et al. (2012) similarly found that most CF isolates belonged to a small number of commonly found types also found among non-CF patients and from the aquatic environment. They noted that clone C and PA14 were the most abundant types found from CF patients. STs 17 (corresponding to clone C), 27 (corresponding to cluster A) and 253 (corresponding to the PA14 clone or cluster B) also featured in an MLST analysis of isolates from patient, animal and environmental sources from Queensland, Australia, emphasizing the global distribution of these types among both CF and non-CF patients (Kidd et al., 2012) . However, studies from The Netherlands found no overlap between strains from CF and non-CF patients, and indicated a highly diverse population among non-CF patients (Tramper-Stranders et al., 2008; van Mansfeld et al., 2010) . These studies, and a recent Irish study (Logan et al., 2012) , all demonstrated shared strains among the CF patients. The Liverpool strain continues to be prevalent among CF patients in the UK, particularly in some centres, with an overall incidence of approximately 10 %; however it should be noted that some 32 % of these were from a single centre with a high prevalence of this strain. This strain is remarkable in that it is confined to CF patients, although it has recently been recovered from a 68-year-old patient with no mention of CF (unpublished observation). Similarly, an Australian study demonstrates particular types apparently confined to CF patients (Kidd et al., 2012) . Nevertheless, the authors suggest that these are randomly acquired from the broader population, with distinct strains becoming associated with CF patients in different geographical locations as a result of colonization events followed by adaptation to the CF lung and subsequent transmission among patients.
The numbers of patients from whom each VNTR cluster was found are almost certainly an underestimate, since, in most cases, similar profiles were observed that differed at one or two further loci, forming a 'VNTR clonal complex' as seen for clone C (Fig. 1) . It can sometimes be difficult to decide the limits of a given type, as has been noted for the
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Liverpool strain, for which an approach of using more than one typing method is advocated (Fothergill et al., 2010) ; one of the advantages of VNTR is that it provides a measure of the distance between such isolates. From AT microarray studies on serial isolates from CF patients, it has been suggested that accessory genes show a high degree of mobility in the context of CF patients' lungs (Cramer et al., 2012) . However, we did not find that to be the case, with consistent accessory gene profiles being found among serial isolates separated by a year or more. Based on the premise that isolates linked by transmission (or from a common source) are more likely to share similar accessory gene content, we found the highly discriminatory accessory gene targets very useful in allowing us to assess the likely extent of transmission between individual patients. Conversely, however, these same targets could not be used to provide a wider identification of the strain itself.
Our study included seeking some of the accessory elements used in the AT microarray method, which uses a combination of core and accessory genome targets to identify clonal lineages, based on the corollary that each lineage has a specific repertoire of segments of each (Cramer et al., 2010; Wiehlmann et al., 2007) . A number of the accessory targets are markers for genomic islands and prophage elements. Based on VNTR, MLST and bla OXA-50-like profiles, together with the results of seeking some of the AT microarray accessory targets, our results largely agree with this. Hence it was necessary to look within the particular cluster to find accessory targets that were variably present among representatives and could provide the further discrimination that was necessary to inform epidemiological investigations. Such finer typing is especially valuable for lineages, such as these clusters, that are widely found. With the increasing availability of next generation sequencing, this is an approach that should become feasible on a routine basis, and promises to improve greatly our understanding of transmission patterns among patients, and between patients and their environment.
